ATE375717T1 - Verfahren zur inhibierung der abstossung von transplantaten - Google Patents

Verfahren zur inhibierung der abstossung von transplantaten

Info

Publication number
ATE375717T1
ATE375717T1 AT00915801T AT00915801T ATE375717T1 AT E375717 T1 ATE375717 T1 AT E375717T1 AT 00915801 T AT00915801 T AT 00915801T AT 00915801 T AT00915801 T AT 00915801T AT E375717 T1 ATE375717 T1 AT E375717T1
Authority
AT
Austria
Prior art keywords
tissues
host
immune system
lymphocytes
attack
Prior art date
Application number
AT00915801T
Other languages
English (en)
Inventor
Denise L Faustman
Original Assignee
Denise L Faustman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denise L Faustman filed Critical Denise L Faustman
Application granted granted Critical
Publication of ATE375717T1 publication Critical patent/ATE375717T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
AT00915801T 1999-02-18 2000-02-18 Verfahren zur inhibierung der abstossung von transplantaten ATE375717T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25233199A 1999-02-18 1999-02-18

Publications (1)

Publication Number Publication Date
ATE375717T1 true ATE375717T1 (de) 2007-11-15

Family

ID=22955579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915801T ATE375717T1 (de) 1999-02-18 2000-02-18 Verfahren zur inhibierung der abstossung von transplantaten

Country Status (6)

Country Link
EP (1) EP1154686B1 (de)
AT (1) ATE375717T1 (de)
AU (2) AU763137B2 (de)
CA (1) CA2362161A1 (de)
DE (1) DE60036788T2 (de)
WO (1) WO2000048462A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116292A2 (en) * 2005-04-27 2006-11-02 Genencor International, Inc. Methods for reducing the immunogenicity of cytokines and removal of cell surface markers
WO2023148304A1 (en) 2022-02-04 2023-08-10 Vib Vzw Methods and applications of analyzing the perfusate of an ex situ perfused kidney

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399123A (en) * 1980-04-01 1983-08-16 Oliver Roy F Fibrous tissue dressing or implant
DE69033493D1 (de) * 1989-07-25 2004-08-12 Cell Genesys Inc Homologe rekombination für universelle donorzellen und chimerische säugetierzellen
US6056952A (en) * 1995-08-30 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Selective elimination of T cells that recognize specific preselected targets
AU2845400A (en) * 1998-12-24 2000-07-31 Phairson Medical Inc. Treatment and prevention of immune rejection reactions

Also Published As

Publication number Publication date
EP1154686B1 (de) 2007-10-17
EP1154686A1 (de) 2001-11-21
DE60036788T2 (de) 2008-07-24
EP1154686A4 (de) 2003-07-02
AU763137B2 (en) 2003-07-17
CA2362161A1 (en) 2000-08-24
AU2003255031A1 (en) 2003-11-13
WO2000048462A1 (en) 2000-08-24
AU3701500A (en) 2000-09-04
DE60036788D1 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
Jaffe et al. Synthesis of basement membrane collagen by cultured human endothelial cells.
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
AU6475186A (en) Process for separating motile sperm cells in vitro, fertilization method and penetration medium for sperm cells
ATE246166T1 (de) Verfahren zur reinigung von milchsäure
ATE161041T1 (de) Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
ES2157976T3 (es) Sustrato solido con grupos reactivos hidrofilos sobre la superficie.
DE59402827D1 (de) Verfahren zur gewinnung nativer, oligomerer, glykosylierter ektodomänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
NZ514230A (en) A single step method for lysing cells and cleaving a fusion protein
AU3925295A (en) Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
DE69737460D1 (de) Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ATE375717T1 (de) Verfahren zur inhibierung der abstossung von transplantaten
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
BR9815440A (pt) Células intestinais parasitas viáveis isoladas
DK461985D0 (da) Fremgangsmaade til enzymatisk hydrolyse af d-alfa-aminosyreamider
NO922422L (no) Matrise med adherent bundede celler, samt fremgangsmaate ved fremstilling av virus/virusantigener
Kanoza et al. Isolation and identification of epithelial-like cells in culture by a collagenase-separation technique
AU3980595A (en) Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
DE69117521T2 (de) Verfahren zur herstellung von 2-alkansäureenantiomeren
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
DK184886A (da) Fremgangsmaade til fremstilling af celleadhaesionsinhibitorer
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
Carlsson Kinetic Studies of the ADP-Ribosylation of HSP-83 in Chicken Embryo Fibroblast Cells
Plotkin A study of the adherence of Bordetella bronchiseptica to mammalian cells.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties